Free Trial

Chemours (CC) Competitors

$26.57
-0.43 (-1.59%)
(As of 05/24/2024 ET)

CC vs. HUN, ASH, BCPC, IOSP, NGVT, OLN, HWKN, PRM, FMC, and FUL

Should you be buying Chemours stock or one of its competitors? The main competitors of Chemours include Huntsman (HUN), Ashland (ASH), Balchem (BCPC), Innospec (IOSP), Ingevity (NGVT), Olin (OLN), Hawkins (HWKN), Perimeter Solutions (PRM), FMC (FMC), and H.B. Fuller (FUL). These companies are all part of the "basic materials" sector.

Chemours vs.

Huntsman (NYSE:HUN) and Chemours (NYSE:CC) are both mid-cap basic materials companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, community ranking, risk, valuation, profitability, dividends, analyst recommendations, media sentiment and institutional ownership.

Huntsman has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500. Comparatively, Chemours has a beta of 1.99, indicating that its stock price is 99% more volatile than the S&P 500.

Huntsman has a net margin of -1.49% compared to Huntsman's net margin of -5.51%. Huntsman's return on equity of 46.67% beat Chemours' return on equity.

Company Net Margins Return on Equity Return on Assets
Huntsman-1.49% 0.67% 0.32%
Chemours -5.51%46.67%4.49%

Huntsman pays an annual dividend of $1.00 per share and has a dividend yield of 4.0%. Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 3.8%. Huntsman pays out -192.3% of its earnings in the form of a dividend. Chemours pays out -46.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Huntsman has increased its dividend for 4 consecutive years. Huntsman is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

In the previous week, Huntsman had 4 more articles in the media than Chemours. MarketBeat recorded 11 mentions for Huntsman and 7 mentions for Chemours. Chemours' average media sentiment score of 0.65 beat Huntsman's score of 0.35 indicating that Huntsman is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Huntsman
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Chemours
4 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Huntsman has higher revenue and earnings than Chemours. Huntsman is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Huntsman$6.11B0.71$101M-$0.52-48.08
Chemours$6.03B0.66-$238M-$2.17-12.24

Chemours received 7 more outperform votes than Huntsman when rated by MarketBeat users. However, 66.49% of users gave Huntsman an outperform vote while only 61.01% of users gave Chemours an outperform vote.

CompanyUnderperformOutperform
HuntsmanOutperform Votes
619
66.49%
Underperform Votes
312
33.51%
ChemoursOutperform Votes
626
61.01%
Underperform Votes
400
38.99%

84.8% of Huntsman shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 5.6% of Huntsman shares are held by insiders. Comparatively, 0.5% of Chemours shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Huntsman presently has a consensus target price of $26.73, indicating a potential upside of 6.91%. Chemours has a consensus target price of $31.63, indicating a potential upside of 19.03%. Given Huntsman's stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Huntsman.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Huntsman
2 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.10
Chemours
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Huntsman beats Chemours on 14 of the 21 factors compared between the two stocks.

Get Chemours News Delivered to You Automatically

Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CC vs. The Competition

MetricChemoursChemicals & allied products IndustryMaterials SectorNYSE Exchange
Market Cap$3.96B$6.38B$2.94B$17.80B
Dividend Yield3.70%2.28%5.13%3.55%
P/E Ratio-12.249.50137.4822.25
Price / Sales0.6647.55841,664.2010.27
Price / Cash5.419.9223.7018.96
Price / Book5.252.244.035.91
Net Income-$238M$249.45M$166.48M$976.87M
7 Day Performance-8.03%-2.68%-0.66%-1.53%
1 Month Performance-1.70%3.72%4.59%3.68%
1 Year Performance-5.14%8.98%18.25%24.48%

Chemours Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HUN
Huntsman
2.79 of 5 stars
$25.22
+2.0%
$26.73
+6.0%
-1.8%$4.36B$6.11B-48.506,000Options Volume
ASH
Ashland
4.6712 of 5 stars
$98.10
+0.1%
$106.44
+8.5%
+14.1%$4.92B$2.19B26.023,800Analyst Downgrade
BCPC
Balchem
4.8189 of 5 stars
$155.27
+0.5%
$170.00
+9.5%
+25.1%$5.03B$922.44M43.861,302Positive News
IOSP
Innospec
4.6148 of 5 stars
$131.40
+1.9%
N/A+33.5%$3.28B$1.95B22.312,400Positive News
NGVT
Ingevity
1.9301 of 5 stars
$55.12
+1.0%
$55.00
-0.2%
-6.5%$2.00B$1.69B-17.721,700Positive News
OLN
Olin
4.8645 of 5 stars
$56.52
+1.5%
$60.00
+6.2%
+3.1%$6.75B$6.83B20.337,326Positive News
HWKN
Hawkins
3.8238 of 5 stars
$76.50
-1.6%
$74.00
-3.3%
+95.7%$1.60B$935.10M21.98846
PRM
Perimeter Solutions
1.5359 of 5 stars
$7.92
+1.9%
$8.50
+7.3%
+29.4%$1.15B$322.11M-34.43219Gap Up
FMC
FMC
4.714 of 5 stars
$66.27
-0.7%
$70.56
+6.5%
-41.1%$8.27B$4.49B7.406,600
FUL
H.B. Fuller
3.0891 of 5 stars
$80.41
+1.1%
$86.20
+7.2%
+23.8%$4.38B$3.51B29.247,200

Related Companies and Tools

This page (NYSE:CC) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners